An In Vivo and In Vitro Comparison of the Effects of b2-a2 and b3-a2 p210BCR-ABL Splice Variants on Murine 32D Cells

References

• Fialkow P. J., Jacobson R. J., Papayannopoulou T. Chronic myelocytic leukemia: clonal origin in a stem cell common to the granulocyte, erythrocyte, platelet and monocyte/macrophage. American Journal of Medicine 1977; 63: 125–130
   PubMed Web of Science ®Google Scholar
• Silver R. T. Chronic myeloid leukemia. A perspective of the clinical and biological issues of the chronic phase. Hematology Oncology Clinics North America 1990; 4: 319–335
   PubMed Web of Science ®Google Scholar
• Caspersson T., Gahrton G., Linsten J., Zech L. Identification of the Philadelphia chromosome on a number 22 by quinacrine mustard fluorescence analysts. Experimental Cell Research 1970; 63: 238–240
   PubMedGoogle Scholar
• Nowell P. C., Hungerford D. A. Chromosome studies on normal and leukemic human leucocytes. Journal of the National Cancer Institute 1960; 25: 85–88
   PubMed Web of Science ®Google Scholar
• Rowley J. D. A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining. Nature 1973; 243: 290–293, (letter)
   PubMed Web of Science ®Google Scholar
• De Klein A., Van Kessel A. G., Grosveld G., Bartram C. R., Hagemeijer A., Bootsma D., Spurr N. K., Heisterkamp N., Groffen J., Stephenson J. R. A cellular oncogene is translocated to the Philadelphia chromosome in chronic myelocytic leukaemia. Nature 1982; 300: 765–767
   PubMed Web of Science ®Google Scholar
• Bartram C. R., De Klein A., Hagemeijer A., Van Agthoven T., Guerts van Kessel A., Bootsma D., Grosveld G., Ferguson-Smith M. A., Davies T., Stone M., Heisterkamp N., Stephenson J. R., Groffen J. Translocation of c-abl oncogene correlates with the presence of a Philadelphia chromosome in chronic myelocytic leukaemia. Nature 1983; 306: 277–280
   PubMed Web of Science ®Google Scholar
• Shtivelman E., Lifshitz B., Gale R. P., Roe B. A., Canaani E. Alternative splicing of RNAs transcribed from the human abl gene and from the bcr-abl fused gene. Cell 1986; 47: 277–284
   PubMed Web of Science ®Google Scholar
• Scherle P. A., Dorschkind K., Witte O. N. Clonal lymphoid progenitor cell lines expressing the BCR/ABL oncogene retain full differentiative function. Proceedings of the National Academy Science USA 1990; 87: 1908–1912
   PubMed Web of Science ®Google Scholar
• Gishizky M. L., Witte O. N. Initiation of deregulated growth of multipotent progenitor cells by bcr-abl. in vitro. Science 1992; 256: 836–839
   PubMed Web of Science ®Google Scholar
• Elefanty A. G., Cory S. Hematologic disease induced in Balb/c mice by a bcr-abl retrovirus is influenced by the infection conditions. Molecular and Cellular Biology 1992; 12: 1755–1763
   PubMed Web of Science ®Google Scholar
• Daley G. Q., Baltimore D. Transformation of an interleukin 3-dependent haematopoietic cell line by the chronic myelogenous leukemia-specific P210bcr/abl protein. Proceedings of the National Academy Science USA 1988; 85: 9312–9316
   PubMed Web of Science ®Google Scholar
• Mandanas R. A., Boswell H. S., Lu L., Leibowitz D. BCR/ABL confers growth factor independence upon a murine myeloid cell line. Leukemia 1992; 6: 796–800
   PubMed Web of Science ®Google Scholar
• Sirard C, Lanueville P., Dick J. Expression of bcr-abl abrogates factor-dependent growth of human hematopoietic MO7E cells by an autocrine mechanism. Blood 1994; 83: 1575–1585
   PubMed Web of Science ®Google Scholar
• Engelman A., Rosenberg N. bcr/abl and src but not myc and ras replace v-abl in lymphoid transformation. Molecular and Cellular Biology 1990; 10: 4365–4369
   PubMed Web of Science ®Google Scholar
• Honma Y., Kasukabe T, Hozumi M., Maseki N., Sakurai M., Sakashita A., Tsuruoka N. Induction of differentiation of human leukemia cells with a structurally altered c-abl (bcr/abl) gene by herbimycin A, an inhibitor of tyrosine kinase activity. Leukemia 1992; 6: 229–231, (letter)
   PubMed Web of Science ®Google Scholar
• Laneuville P., Sun G., Timm M., Vekemans M. Clonal evolution in a myeloid cell line transformed to inter-leukin-3 independent growth by retroviral transduction and expression of p210bcr/abl. Blood 1992; 80: 1788–1797
   PubMed Web of Science ®Google Scholar
• Carlesso N., Griffin J. D., Drucker B. J. Use of a temperature-sensitive mutant to define the biological effects of the p210BCR-ABL tyrosine kinase on proliferation of a factor-dependent murine myeloid cell line. Oncogene 1994; 9: 149–156
   PubMed Web of Science ®Google Scholar
• Daley G. Q., Van Etten R. A., Baltimore D. Induction of chronic myelogenous leukemia in mice by the P210bcr/abl gene of the Philadelphia chromosome. Science 1990; 247: 824–830
   PubMed Web of Science ®Google Scholar
• Kelliher M. A., McLaughlin J., Witte O. N., Rosenburg N. Induction of a chronic myelogenous leukemia-like syndrome in mice with v-abl and BCR/ABL. Proceedings National Academy Science USA 1990; 87: 6649–6653
   PubMed Web of Science ®Google Scholar
• Pear W. S., Miller J. P., Xu L., Pui J. C., Soffer B., Quackenbush R. C., Pendergast A. M., Bronson R., Aster J. C., Scott M. L., Baltimore D. Efficient and rapid induction of chronic myelogenous leukemia-like myeloproliferative disease in mice receiving p210 bcr/abl-transduced bone marrow. Blood 1998; 92: 3780–3792
   PubMed Web of Science ®Google Scholar
• Gishizky M. L., Johnson-White J., Witte O. N. Efficient tranplantation of BCR-ABL-induced chronic myelogenous leukemia-like syndrome in mice. Proceedings of the National Academy of Science USA 1993; 90: 3755–3759
   PubMed Web of Science ®Google Scholar
• Cesano A., Hoxie J. A., Lange B., Nowell P. C., Bishop J., Santoli D. The severe combined immunodeficient (SCID) mouse as a model for human myeloid leuke-mias. Oncogene 1992; 7: 827–836
   PubMed Web of Science ®Google Scholar
• Voncken J. W., Kaartinen V., Pattengale P. K., Germeraad W. T.V., Groffen J., Heisterkamp N. BCR/ABL P210 and P190 cause distinct leukemia in transgenic mice. Blood 1995; 86: 4603–4611
   PubMed Web of Science ®Google Scholar
• Wang J. C.Y., Lapidot T., Cashman J. D., Doedens M, Addy L., Sutherland D. R., Nayar R., Laraya P., Minden M., Keating A., Eaves A. C., Eaves C. J., Dick J. E. High level engraftment of NOD/SCID mice by primitive normal and leukemia hematopoietic cells from patients with chronic myeloid leukemia in chronic phase. Blood 1998; 91: 2406–2414
   PubMed Web of Science ®Google Scholar
• Namikawa R., Ueda R., Kyoizumi S. Growth of human leukemias in the human marrow environment of SCID-hu mice. Blood 1993; 82: 2526–2536
   PubMed Web of Science ®Google Scholar
• Sawyers C. L., Gishizky M. L., Quan S., Golde D. W., Witte O. N. Propogation of human blastic myeloid leukemias in the SCID mouse. Blood 1992; 79: 2089–2098
   PubMed Web of Science ®Google Scholar
• Beran M, Pisa P., O'Brien S., Kurzrock R., Siciano M., Cork A., Andersson B. S., Kohli V., Kantarjian H. Biological properties and growth in SCID mice of a new myelogenous leukemia cell line (KBM-5) derived from chronic myelogenous leukemia cells in the blastic phase. Cancer Research 1993; 53: 3603–3610
   PubMed Web of Science ®Google Scholar
• De Lord C., Clutterbuck R. D., Powles R. L., Min T., Titley J. C., Millar J. L. Human Philadelphia chromosome-positive chronic myeloid leukemia: a potential model for antisense therapy. Experimental Hematology 1993; 21: 826–828
   PubMed Web of Science ®Google Scholar
• Pirruccello S. J., Jackson J. D., Sharp J. G. The leukemic myeloid cell line OMA-AML-1: an in vitro model of hematopoietic cell differentiation. Leukemia and Lymphoma 1994; 13: 169–178
   PubMed Web of Science ®Google Scholar
• Lewis I. D., McDiarmid L. A., Samels L. M., To L. B., Hughes T. P. Establishment of a reproducible model of chronic-phase chronic myeloid leukemia in NOD/SCID mice using blood-derived mononuclear or CD34+ cells. Blood 1998; 91: 630–640
   PubMed Web of Science ®Google Scholar
• Laneuville P., Heisterkamp N., Groffen J. Expression of the chronic myelogenous leukemia-associated p210bcr/abl oncoprotein in a murine IL-3 dependent myeloid cell line. Oncogene 1991; 6: 275–282
   PubMed Web of Science ®Google Scholar
• Mills K. I., Benn P., Birnie G. D. Does the breakpoint within the major breakpoint cluster region (M-bcr) influence the duration of the chronic phase in chronic myeloid leukemia? An analytical comparison of current literature. Blood 1991; 78: 1155–1161
   PubMed Web of Science ®Google Scholar
• Greenberger J. S., Sakakeeny M. A., Humphries R. K., Eaves C. J., Eckner R. J. Demonstration of permanent factor-dependent multipotential (erythroid/neutrophil/basophil) hematopoietic progenitor cell lines. Proceedings of the National Academy Science USA 1983; 80: 2931–2935
   PubMed Web of Science ®Google Scholar
• Mes Masson A. M., McLaughlin J., Daley G. Q., Paskind M., Witte O. N. Overlapping cDNA clones define the complete coding region for the P210c-abl gene product associated with chronic myelogenous leukemia containing the Philadelphia chromosome. Proceedings of the National Academy Science USA 1986; 83: 9768–9772
   PubMed Web of Science ®Google Scholar
• Baker F. J., Silverton R. E. Introduction to medical laboratory technology. 5th Edition. Butter-worths, London; Boston 1976
   Google Scholar
• Hoebee B., De Stoppelaar J. M., Suijkerbutjk R. F., Monard S. Isolation of rat chromosome-specific paint probes by bivariate flow sorting followed by degenerate oligonucleotide primed-PCR. Cytogenetics and Cellular Genetics 1994; 66: 277–282
   PubMedGoogle Scholar
• Roth M. S., Antin J. H., Ash R., Terry V. H., Gotlieb M., Silver S. M., Ginsburg D. Prognostic significance of Philadelphia chromosome-positive cells detected by the polymerase chain reaction after allogeneic bone marrow transplant for chronic myelogenous leukemia. Blood 1992; 79: 276–282
   PubMed Web of Science ®Google Scholar
• Hariharan I. K., Adams J. M., Cory S. bcr-abl oncogene renders myeloid cell line factor independent: potential autocrine mechanism in chronic myeloid leukemia. Oncogene Research 1988; 3: 387–399
   PubMedGoogle Scholar
• Wong P. M., Chung S. W., Dunbar C. E., Bodine D. M., Ruscetti S., Nienhuis A. W. Retrovirus-mediated transfer and expression of the interleukin-3 gene in mouse hematopoietic cells result in a myeloproliferative disorder. Molecular and Cellular Biology 1989; 9: 798–808
   PubMed Web of Science ®Google Scholar
• Metcalf D., Begley C. G., Johnson G. R., Nicola N. A., Lopez A. F., Williamson D. J. Effects of purified bacterially synthesized murine multi-CSF (IL-3) on hematopoiesis in normal adult mice. Blood 1986; 68: 46–57
   PubMed Web of Science ®Google Scholar
• Donahue R. E., Seehra J., Metzger M., Lefebvre D., Rock B., Carbone S., Nathan D. G., Garnick M., Sehgal P. K., Latson D., LaVallie E., McCoy J., Schendel P. F., Norton C., Turner K., Yang Y-C., Clark S. C. Human IL-3 and GM-CSF act synergistically in stimulating haematopoiesis in primates. Science 1988; 241: 1820–1823
   PubMed Web of Science ®Google Scholar
• Kanakura Y., Drucker B., Cannistra S. A., Furukawa Y., Torimoto Y., Griffin J. D. Signal transduction of the human granulocyte-macrophage colony-stimulating factor and interleukin-3 receptors involves tyrosine phosphorylation of a common set of cytoplasmic proteins. Blood 1990; 76: 706–715
   PubMed Web of Science ®Google Scholar